This engaging session will cover the historical roots and current trends in health care unionization, explore the legal and regulatory frameworks, and discuss the practical steps physicians can take if considering collective action. We’ll examine potential impacts on patient care,…
Presented by the Committee on Ethics, Grievances, and Professional Standards, the Ethics Forum alerts physicians to the ethical implications of issues that arise in daily practice and offers information on issues at the intersection of ethics, medicine, and professionalism. The…
The new ERPO training, developed by the Massachusetts Medical Society in partnership with Boston Medical Center, provides Massachusetts clinicians with the knowledge and practical skills needed to recognize warning signs, navigate the ERPO process, and take timely action to protect…
Glucagon-like peptide-1 (GLP-1) has emerged as a key regulator in metabolic health, with profound implications for diabetes management, weight loss, and cardiovascular protection. The 135th Annual Shattuck Lecture explores the discovery, physiological role, and therapeutic applications of GLP-1 receptor agonists…
This course aims to provide information and increase the ability to recognize, evaluate, and effectively treat acute and chronic pain. The course is designed to benefit pain physicians, general anesthesiologists, pharmacists, CRNAs, nurse practitioners, and other health care professionals through…
Lung cancer care continues to evolve rapidly, driven by advances in biomarker testing, radiation therapy techniques, and the development of new systemic therapies. These innovations have improved outcomes but also introduced complexity in clinical decision-making, requiring coordinated, up-to-date care across…
The NextGen Clinical Trial Investigator Training is a one-day educational program with designed for investigators who currently lead or would like to lead clinical trials. The series includes lectures and panel discussions from leaders across the University of Missouri System,…
Importance Research in acute lymphoblastic leukemia (ALL) is translating into rapid changes in therapy and outcomes. Historically, adult ALL was treated with intensive chemotherapy extending over 2.5 to 3 years. This established tradition, accepted because of the high cure rates in…
The article assesses research on private equity ownership’s influence on health care quality. A review of several prominent studies supports the conclusion that private equity ownership does not have a universally positive or negative effect. Past research has found that…
Private equity (PE) investments in health care have grown to over $750 billion in the past decade and include every segment of the US health sector. Although PE investments can provide capital and improve efficiency of health service delivery, PE’s…
© 2025
American Board of Medical Specialties | Policies | Sitemap | Terms of Use | www.abms.org
